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Up-regulation of renal and vascular nitric oxide synthase in iron-
deficiency anemia. Anemia is frequently associated with increased cardiac
output and reduced vascular resistance. The latter has been attributed to
reduced inactivation of nitric oxide (NO) by hemoglobin. We hypothe-
sized that in addition to reducing NO inactivation, anemia may up-
regulate NO production. To test this hypothesis, male Sprague-Dawley
rats with chronic iron-deficiency anemia (produced by multiple phiebot-
omies and an iron-free diet) were studied. The results were compared with
those obtained in a group of normal control animals. The anemic group
showed marked increases in urinary excretion, plasma concentration, and
renal and aorta tissue contents of NO metabolites (total nitrates and
nitrites, NOx). This was accompanied by a significant rise in urinary
excretion of cGMP, the second messenger for NO. In addition, NO
synthase (NOS) activity and endothelial constitutive (eNOS) and induc-
ible NOS (,NOS) proteins of the thoracic aorta were markedly increased
in the anemic group. Likewise, renal tissue ecNOS and OS proteins were
greatly increased in the anemic animals. NOS activity and protein values
were inversely related to hematocrit and directly related to plasma, tissue
and urinary NOx. The constellation of these findings points to an
increased NOS expression and NO production as opposed to the mere
reduction of NO inactivation in iron-deficiency anemia. Further studies
are planned to determine the mechanism of NOS up-regulation in
iron-deficiency anemia.
Chronic anemia is invariably associated with reduced systemic
vascular resistance and increased cardiac output [1, 23. The
mechanism of anemia-induced fall in vascular resistance has not
been fully elucidated. Systemic vasodilation and reduced blood
viscosity have been implicated. In a recent study, Anand et al
found a significant increase in forearm blood flow and a marked
decrease in forearm vascular resistance in a group of men with
severe anemia [3]. These abnormalities were promptly reversed by
partial correction of anemia with packed red cell transfusion.
Moreover, administration of nitric oxide synthase (NOS) inhibi-
tor, NGmonomethylLarginine (L-NMMA), caused a threefold
greater reduction of forearm blood flow in the anemic patients as
compared to that seen in the normal control group and the
anemic group treated with blood transfusion. Based on these data,
the authors concluded that endothelial-derived relaxing factor
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(EDRF) activity is increased in severe anemia. In view of the
known nitric oxide (NO)-inhibitory property of hemoglobin [43,
they attributed this phenomenon to reduced inactivation of
EDRF by hemoglobin in the anemic subjects [3]. However, the
authors acknowledged that the available data did not exclude
possible up-regulation of NO production. We hypothesized that in
addition to decreasing NO inactivation, anemia may up-regulate
NO production. The present study was, therefore, designed to test
this hypothesis. To this end, plasma concentration, tissue content,
and urinary excretion of NO metabolites [that is, nitrates and
nitrites (NOx)], its second messenger (cGMP), aorta NOS activ-
ity, renal and aorta endothelial constitutive (NOS) and inducible
NOS (NOS) proteins were compared in rats with chronic iron-
deficiency anemia and their normal control counterparts. The
results showed convincing evidence of up-regulation of both
ecN0S, 1NOS and NO production in the anemic animals.
METHODS
Animal model
Male Sprague-Dawley rats (Harlers Sprague Dawley, Inc., In-
dianapolis, IN, USA) weighing 350 g were randomly assigned to
the anemic and the normal control groups. Animals assigned to
the anemic group were fed an iron-free diet (prepared by Purina
Test Diets Inc., Richmond, IN, USA) for six weeks and were
subjected to multiple phiebotomies as needed to produce iron-
deficiency anemia. The animals assigned to the control group
were fed regular rat chow (Purina Rat Chow; Purina Mills,
Brentwood, MO, USA). The animals were studied after six weeks.
Body weight, arterial blood pressure and hematocrit were deter-
mined. Blood pressure was measured by a tail sphygmomanome-
ter (Harvard Apparatus, South Natick, MA, USA). Animals were
placed in individual metabolic cages and urine collected over thy
ice for measurements of creatinine, combined nitrates and nitrites
(NOx) and cGMP. At the conclusion of the observation period,
animals were anesthetized with pentobarbital (50 mg/kg) and
killed by exsanguination using cardiac puncture. Thoracic aorta
and kidneys were removed immediately and processed for mea-
surements of NOS activity and protein mass as described below.
Tissue preparation
Rats were sacrificed by exsanguination and kidney and thoracic
aorta excised, cleaned with PBS, frozen in liquid nitrogen and
stored at —75°C. Homogenates (25% wt/vol) were prepared in 10
mM HEPES buffer, pH 7.4, containing 320 m sucrose, 1 mM
EDTA, 1 mivi DTT, 10 p.g/ml leupeptin and 2 ig/mI aprotinin at
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o to 4°C with the aid of a tissue grinder fitted with a motor-driven
ground glass pestle. Homogenates were centrifuged at 14,000 rpm
for 20 minutes with a microcentrifuge at 4°C, and the supernatant
was used for determination of NOS activity and Western blot
analysis. Protein concentration was determined by using a Bio-
Rad kit (Bio-Rad Laboratories, Hercules, CA, USA).
Measurements of plasma, tissue and urine NOx
The concentration of total nitrate and nitrite in the test samples
was determined by a modification of the procedure described by
Braman and Hendrix [5] using the purge system of a Sievers
Instruments Model 270B Nitric Oxide Analyzer (NOA 228;
Sievers Instruments Inc., Boulder, CO, USA). Briefly, samples of
plasma and tissue preparations were first diluted and deprotein-
ized using chilled 100% ethanol (plasma/ethanol = 1:2 vol/vol),
and the urine samples were diluted ten times in distilled water
prior to analysis. A saturated solution of VC13 in 1 M HCI was
prepared and filtered prior to use. Five milliliters of this reagent
were added to the purge vessel and purged with nitrogen gas for
5 to 10 minutes prior to use. To minimize foaming of the residual
proteins in the samples, 100 .d of the 1/30 dilution of antifoam C
(Sigma Chemical Co., St. Louis, MO, USA) were added to the
VCI3 reagent. The purge vessel was equipped with a cold water
condenser and a water jacket to permit heating of the reagent to
95°C using a circulating water bath. The hydrochloric acid vapors
were removed by a gas bubbler containing —15 ml of 1 M NaOH.
The gas flow rate into the chemiluminescence detector was
controlled using a needle valve adjusted to yield a cell pressure of
—7 torr. The flow rate of nitrogen into the purge vessel was
adjusted to prevent vacuum distillation of the reagent.
Samples were injected into the purge vessel to react with the
VC13/HC1 reagent which converted nitrate, nitrite and S-nitroso
compounds to NO. The NO produced was stripped from the
reaction chamber (by purging with nitrogen and vacuum) and
detected by ozone-induced chemiluminescence in the chemilumi-
nescence detector. The signal generated (NO peak and peak area)
was recorded and processed by a Hewlett Packard Model 3390
Integrator. In a typical assay, 5 jxl of the test sample were injected
to the purge vessel, and all samples were run in triplicate.
Standard curves were constructed using various concentrations
of NO3 (5 to 100 xM) relating the luminescence produced to the
given NO3 concentrations of the standard solutions. The amount
of N02/N03 in the test sample was determined by interpolation of
the result into the standard curve.
NOS activity assay
Thoracic aorta NOS activity was measured as previously de-
scribed [61. In brief enzyme reactions were conducted at 37°C for
30 minutes in 40 pJ of the supernatant and 100 jil of 40 mM
potassium phosphate buffer, pH 7.4, containing 4.8 mM DL-valine,
1 mM NADPH, 1 m'vi MgC12, 2 mivi CaCI2, 40 JLM L-arginine, 2
j.g/ml calmodulin and 0.04 JLM L-[3H] arginine (59 Ci/mM; Am-
ersham Life Science Inc., Arlington Heights, IL, USA). On each
occasion, parallel measurements were obtained in the presence
and absence of 1 m NGmethylLarginine. The reactions were
terminated by 0.86 ml ice-cold stop buffer containing 10 mrvi
EDTA. Two-hundred fifty milligrams of the Na form of Dowex
50W-X8 resin was added to a 0.25 ml aliquot of the reaction
mixture and shaken for at least five minutes prior to microcen-
trifugation to remove the remaining L-arginine. The Na form of
Table 1. Comparison of body weight, hematocrit and systolic blood
pressure in rats with iron-deficiency anemia and the normal control
group.
Groups N
Body
weight
g
Hematocrit
%
Blood
pressure
mmHg
Anemic 6 357 12.3 35.8 0.9 139 3.24
Control 7 368 17.2 47.5 0.92 129 2.80
P values — NS <0.01 NS
Dowex SOW was prepared by washing the H form of the resin
(100 to 200 mesh, Bio-Rad Inc.) with 1 M NaOH four times and
then washing with H20 until the pH fell below 7.5. A 100 pi
aliquot of the latter supernatant (containing L-citrulline) was
mixed with 10 ml of scintillation cocktail in a 20 ml scintillation
vial and counted by a Beckman LS-9000 counter (Beckman
Instruments Inc., Fullerton, CA, USA). Net radioactivity was
determined by substrating the cpm observed in the presence of
Nmethyl-L-arginine from that observed in the absence of
NGmethylLarginine. NOS activity was determined from the
production of [3H1-citrullin per minute per mg protein.
Western blot analysis
These measurements were carried out to determine the ecNOS
and NOS proteins in the renal and aorta tissue preparations as
previously described [7, 8]. Anti-ecNOS monoclonal antibody,
anti-Mac NOS-I, anti-mouse IgG-HRP, human endothelial and
mouse macrophage positive controls were supplied by Transduc-
tion Laboratories (Lexington, KY, USA). Briefly, aorta and
kidney tissue preparations (50 rg protein for ecN0S, 150 j.tg
protein for ,NOS) were size-fractionated on 4 to 12% Tris-Glycine
gel (Novex, San Diego, CA, USA) at 120 V for three hours. After
electrophoresis, proteins were blotted onto hybond-ECL mem-
brane (Amersham Life Science Inc., Arlington Heights, IL, USA)
at 500 mA for 120 minutes using the Novex transfer system. The
membrane was prehybridized in 25 ml of buffer A (10 mtvt
Tris-HC1, pH 7.5, 100 m NaCl, 0.1% Tween-20 and 5% nonfat
dry milk) for one hour and then hybridized for an additional
one-hour period in the same buffer containing 10 1id of anti-ecNOS
monoclonal antibody (1:2500). The membrane was then washed
for 30 minutes in a shaking bath, changing the wash buffer (buffer
A, without nonfat milk) every five minutes prior to one hour of
incubation in buffer A plus diluted (1:2500) anti-mouse IgG-HRP
(horseradish peroxidase). Experiments were carried out at room
temperature. The washes were repeated before the membrane
was developed with a light emitting nonradioactive method using
ECL reagent purchased from Amersham Inc. The membrane was
then subjected to autoradiography for 10 to 15 seconds. The
autoradiographs were scanned with a laser densitometer (Model
PD121I; Molecular Dynamics, Sunnyvale, CA, USA) to deter-
mine the relative optical densities of the bands.
Other measurements
Hematocrit and urinary and plasma creatinine concentrations
were determined using standard laboratory techniques. Plasma
and urine cyclic guanosinc monophosphate (cGMP) were mea-
sured by radioimmunoassay using a kit purchased from DuPont!
New England Nuclear Inc. (Boston, MA, USA) as described
previously [9].
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Data analysis
Data are presented as mean 5EM. Student's t-test and
regression analysis were used in statistical evaluation of the data.
P values equal to or less than 0.05 were considered significant.
RESULTS
General data
Data are summarized in Table 1. By design, hematocrit in the
anemic group was significantly (P < 0.01) lower than that of the
normal control group. However, arterial blood pressure in the
anemic group was comparable with that found in the control
group. The body wt obtained at the conclusion of the observation
period was insignificantly lower in the anemic group as compared
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to that found in the control group despite comparable baseline
values.
Plasma, tissue and urinary NOx
Data are shown in Figure 1. Plasma NOx in the anemic group
was threefold greater than the corresponding value found in the
normal control group (P < 0.01). In addition, renal and aorta
tissue NOx contents were significantly increased in the anemic
group. Likewise, urinaly NOx excretion was markedly elevated in
the anemic animals as compared to that observed in the control
group (P < 0.01). However, fractional excretion of NOx in the
anemic group (10.7 1.8%) was similar to that found in the
normal control group (11.9 1.1%,P = NS). These observations
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Fig. 1. Plasma concentration, urinary excretion, and aorta and renal tissue contents of NO metabolites (combined N02 and N03, [NOx]) in rats
with iron-deficiency anemia and their normal control (NL) counterparts (N = 6 in each group; *P < 0.01)
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Fig. 2. Urinary cGMP excretion in rats with iron-deficiency anemia and
their normal control (NL) counterparts (N = 6 in each group; P < 0.01).
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Fig. 3. NOS activity of the thoracic aorta in rats with iron-deficiency
anemia and the normal control (NL) group (N = 6 in each group; *P <
0.01).
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Fig. 5. (A) Representative Western blot of the aorta iNOS in two anemic
and two normal control rats. (B) Relative optical densities of Western
blots of the aorta iNOS in the anemic and normal control (NL) animals
(N = 6 in each group; *P < 0.01).
urinary NOx in the anemic animals was accompanied by a parallel
rise in thoracic aorta NOS activity (Fig. 3). In comparison with the
normal control group, the anemic animals exhibited a threefold
increase in the aortic tissue NOS activity at the end of the study
period (P < 0.01 vs. control value). The rise in the aorta NOS
activity was accompanied by a parallel rise in both CCNOS and
NOS proteins in this tissue (Figs. 4 and 5). The up-regulation of
*
NL Anemic
NL Anemic
are suggestive of augmented NO production in the anemic
animals.
Urinary cGMP
Data are shown in Figure 2. The anemic group showed a
significant increase in urinary excretion of cGMP as compared to
the normal control group. Although the mean plasma cGMP in
the anemic group was higher than that of the control group, the
difference did not reach statistical significance (data not shown).
NOS activity and proteins
Data are shown in Figures 3 to 7. The rise in plasma, tissue and
—- -— a -l4OkDa NOS
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Fig. 6. (A) Representative Western blot of the renal tissue NOS in two
anemic and two normaJ control rats. (B) Optical densities of the Western
blots in the anemic and normal control (NL) groups (N = 6 in each group;
P < 0.01.
CCNOS and ,NOS was not limited to aorta. In fact, kidney, which
is a highly vascular tissue, showed an even greater relative
elevation of CCNOS and NOS proteins in the anemic animals
(Figs. 6 and 7). These observations suggest that the rise in tissue
contents, plasma concentration and urinary excretion of NOx in
the anemic group must be due to up-regulation of vascular NOS
expression.
Correlations
A significant inverse correlation was found between hematocrit
and plasma concentration and urinary excretion of NOx in the
study animals (r = —0.88, P < 0.01 and r = —0.74, P < 0.05 for
plasma and urine measurements, respectively). Likewise, hemat-
ocrit was negatively related to aorta and renal eCNOS protein mass
(r =
—0.90, P < 0.01 and r = —0.92, P < 0.01, respectively), aorta
and renal INOS proteins (r =
—0.94, P < 0.01 and r = —0.84, P <
0.01, respectively) and aorta NOS activity (r = —0.89, P < 0.01).
In addition, urinary cGMP excretion was inversely related to
hematocrit (r =
—0.88, P < 0.01). Plasma concentration and
urinary excretion of NO metabolites were directly related to NOS
activity (r = 0.93, P < 0.01 and r = 0.68, P < 0.05, respectively).
A significant correlation was found between urinary NOx excre-
tion and plasma NOx level (r = 0.75, P < 0.05). Urinary cGMP
excretion significantly correlated with plasma and urinary NOx
levels. Aorta NOS activity was directly related to aorta CNOS and
1NOS proteins (r = 0.86, P < 0.05 and r = 0.90, P < 0.01,
respectively; Fig. 8).
DISCUSSION
The anemic animals employed in the present study exhibited a
significant increase in plasma concentration and urinary excretion
of NO metaholites. This was accompanied by a marked increase in
urinary excretion of cGMP (the second messenger for NO in the
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Fig. 7. (A) Representative Western blots of the kidney iNOS in two
anemic and two normal control (NL) rats. (B) Optical densities of kidney
iNOS in the anemia and normal control groups (N = 6 in each group;
*p < 0.01).
vascular smooth muscle) signifying enhanced biological action of
NO in the anemic animals. The constellation of these findings
points to a marked rise in NO production in the anemic animals.
The observed rise in NO production was accompanied by and
undoubtedly due to the up-regulation of NOS in rats with
iron-deficiency anemia. Both ecN0S and NOS proteins were
markedly elevated in thoracic aorta and the kidney of the anemic
animals. Increased CCNOS and NOS proteins in the anemic
animals was coupled with a marked rise in NOS activity. This
observation suggests that the amount of enzyme present in the
active conformation was equally increased in the anemic animals.
We chose thoracic aorta for measurement of NOS activity and
protein mass primarily because its large size would provide
sufficient endothelial tissue to accommodate the requirements for
these assays. However, as a conduit artery, the aorta tone is not
highly influenced by the vasoactive agents. Nonetheless, the
marked up-regulation of NOS in the aorta may reflect similar
changes in the smaller resistance vessels. In an attempt to examine
this possibility, we studied CcNOS and 1NOS proteins in the
kidney, which is one of the most highly vascular organs harboring
large numbers of resistance arteries, arterioles and capillaries.
The results showed an even greater up-regulation of CCNOS and
NOS in the kidney of the anemic animals relative to those found
in the aorta. This observation confirmed the diffuse nature of
NOS up-regulation in the animals with iron-deficiency anemia.
The precise mechanism by which iron-deficiency anemia up-
regulates eCNOS and NOS is not clear and awaits further inves-
tigation. Several earlier studies have shown that a rise in blood
flow can up-regulate vascular NOS expression. For instance,
increased coronary blood flow by regular exercise has been
reported to up-regulate CCNOS gene expression in dogs [10].
Similarly, dog femoral arteries subjected to increased blood flow
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Fig. 8. Correlation between hematocrit and
plasma concentration of NO (A), urinary
cGMP excretion (B), thoracic aorta NOS
activity (C) and protein mass (D) in the iron-
deficient anemic rats (•) and their normal
control (NL) counterparts.
by creation of arteriovenous fistula exhibit enhanced endotheli-
urn-dependent relaxation [11, 12]. In addition, sustained increase
in coronary blood flow by cardiac pacing augments endothelium—
dependent vasodilation [13]. In contrast, conditions associated
with diminished blood flow such as congestive heart failure are
accompanied by diminished endothelium-dependent vascular re-
laxation [14, 15]. In view of these observations, it is plausible that
up-regulation of vascular CCNOS shown here may have been
mediated by the inherent hyperdynamic circulation in the anemic
animals.
By promoting vasodilation, enhanced NO production can in-
crease blood flow. In this regard, the fall in vascular resistance and
enhanced blood flow in acute dilutional anemia has been shown to
he NO mediated [3, 16, 17]. Conversely, as noted above, increased
blood flow can up-regulate ,NOS expression and NO production
[12—14]. Thus, it can be speculated that enhanced NO production
in anemia may be due to the associated hyperdynamic circulation
inherent to the anemic state. However, the hyperdynamic circu-
latory state itself is largely mediated by enhanced NO availability
in anemia [3, 16, 17]. Thus, the causal relationship between
increased NO and hyperdynamie circulatory state in anemia is
complex. It is plausible that a reduction in blood viscosity together
with a rise in NO availability (decreased inactivation by hemoglo-
bin) may initiate vasodilation and enhanced blood flow which in
turn helps to support continued up-regulation of NO production
in this condition.
Oxyhemoglobin is a potent scavenger of NO [4]. Therefore,
reduced competition by hemoglobin has been suggested to en-
hance NO availability to the vascular smooth muscle, which in
turn promotes vasorelaxation in the anemic state. While this is
partly true, our data clearly demonstrated a marked increase in
urinary excretion of NO metabolites along with marked up-
regulation of NOS activity as well as CNOS and NOS protein
expressions. These findings are indicative of enhanced NO pro-
duction capacity as opposed to the mere reduction of NO
inactivation by hemoglobin in the anemic animals. In a recent
study, Panes et al showed a marked rise in gastric mucosa blood
flow following induction of acute isovolumic anemia in rats [16].
The associated gastric vasodilation and enhanced blood flow was
abrogated by administration of the NOS inhibitor, L-NMMA. The
inhibition of anemia-induced rise in gastric blood flow with
L-NMMA was prevented by concomitant administration of L-
arginine [16]. Based on these observations, the authors concluded
that acute isovolumic anemia may up-regulate NO production in
the gastric mucosa. in another study, Talwar, hussain and Fahim
showed a marked increase in cardiac output, heart rate and stroke
volume and a significant fall in total vascular resistance with
induction of acute isovolumic anemia in eats. This was associated
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with reduced hemodynamic response to administration of NO-
donor, sodium nitroprusside, and NOS activator, acetylcholine
[171. The attenuated hemodynamic response to these agents in the
anemic cats reported by these authors can be readily explained by
up-regulation of vascular NO production shown here. Thus, the
above studies provide indirect, but compelling, evidence for
enhanced vascular NO production in rats [161 and cats [171 with
acute isovolumic anemia. The present study directly demonstrates
the up-regulation of CCNOS and NOS protein expressions coupled
with enhanced production of NO and its second messenger cGMP
in rats with chronic iron-deficiency anemia.
The authors wish to emphasize that the results of the present
study of iron-deficiency anemia may not be applicable to other
types of anemia. This is because the present study was not
designed to dissect the possible effects of iron depletion from
those of the associated anemia per Se. Further studies are planned
to clarify this issue. Likewise, the possible effect(s) of enhanced
endogenous erythropoietin (EPO) production on NO metabolism
could not be discerned from the present data. We have recently
shown that regular administration of recombinant EPO causes a
hematocrit-independent and NO-resistant hypertension in rats
with chronic renal failure [181. However, these observations
cannot be extended to enhanced endogenous EPO production in
the anemic animals with intact kidneys. While the observed
up-regulation of renal ecN0S and NOS in the face of normal
arterial blood pressure is expected to increase renal blood flow, its
possible effects on glomerular and tubular functions are uncertain
and require careful investigation.
In conclusion, our data demonstrate that iron-deficiency ane-
mia in rats results in marked up-regulation of both ecT0S and
NOS expression, leading to increased production of NO and its
second messenger, cGMP. These findings can readily account for
the reported increase in EDRF activity in anemia.
Reprint requests to ND. Vaziri, M.D., Division of Nephrology, UCI
Medical Center, 101 The City Drive, Orange, California 92668, USA.
E-mail: tabotten@uci.edu
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